Region: Europe

The five challenges that will define the Campinos legacy at the EPO

The Portuguese president of the agency was recently appointed to a second term and now has until the end of June 2028 to leave an indelible mark on Europe’s patent story

18 August 2022

How to obtain commercially useful patents for AI in Europe

Although it is tempting to think that such rights are too difficult to secure, there are ways through to getting meaningful protection from the EPO

18 August 2022

Unified Patent Court: an introduction for life sciences companies

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

The UPC is expected to become operational in early 2023. The new court will provide a one-stop shop for patent litigation throughout a large part of Europe, with decisions being made by one centralised court.

18 August 2022

How to successfully protect antibodies at the EPO

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

Antibody therapies are booming, with a majority of the top 10 blockbuster drugs now antibodies. The introduction of a section dedicated to antibody drafting in the Guidelines for Examination at the European Patent Office in March 2021 is an illustration of the importance of antibody patenting.

18 August 2022

Winning IP strategies for small and medium-sized biotechs

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

With the advancement in technologies related to various life sciences fields, the world has seen a significant increase in the number of SMEs in different fields in the life sciences sector, such as pharmaceuticals and biotechnology. SMEs related to biotechnology have contributed to the global market by developing breakthrough products such as therapeutic bio drugs (peptides, antibodies, etc), biomedical devices (biofilms, etc) and diagnostic tools.

18 August 2022

Tips and tricks on how to obtain patent protection for polymorphs

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

Obtaining patent protection for a polymorph in addition to a primary compound patent may be particularly advantageous, especially if filed successively, as the polymorph patent may add extra time to the patent protection for the modification of an approved drug or a clinical candidate.

18 August 2022

Unified Patent Court: strategic considerations for life sciences companies

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2022

The UPC provides an additional forum for European life sciences patent litigation, with new strategic opportunities and challenges that must be navigated.

18 August 2022

UK decision highlights risk surrounding patent enforcement strategies focused on Amazon

The High Court ruling is the country’s first on whether the use of the online platform’s IP procedures can constitute an actionable unjustified threat

11 August 2022

Bolar-like hurdle for generics

The judgment of the Ankara IP court in a case involving a marketing authorisation application demonstrates that an exemption similar to the so-called Bolar exemption can apply to Gx pharmaceutical companies.

10 August 2022

Oppo’s German withdrawal suggests patent dispute with Nokia will be decided in Asia

The Chinese companies' decision to leave such a potentially lucrative growth market is an unprecedented development in SEP licensing battles

08 August 2022

Unlock unlimited access to all IAM content